MSTRO & DataCorps Launch Voyager Program with ‘Mission Control Network’ Initiative

FREDERICK, MD, UNITED STATES, January 21, 2026 /EINPresswire.com/ — MSTRO, Inc., a developer of AI-augmented intelligence ...
Nasdaq

Voyager Provides Update on SOD1 ALS Gene Therapy Program

LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...
Seeking Alpha

Voyager Provides Update on SOD1 ALS Gene Therapy Program

- All other programs remain on track; IND filings expected in 2025 for GBA1 and FA programs - LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (VYGR), a biotechnology ...
Business Insider

Voyager to assess alternate payloads for SOD1 ALS gene therapy program

Voyager Therapeutics (VYGR) has decided to assess alternate payloads related to its gene therapy program for superoxide dismutase 1 amyotrophic lateral sclerosis. Emerging three-month non-human ...